I believe that at these levels ytc is a great buying opportunity. We are not far from a DFS, and the last time I looked they were hoping for a very low production cost of $360. Do the math.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025